The effects of biofeedback in diabetes and essential hypertension.

Department of Psychiatry, University of Toledo, Toledo, OH 43614-2598, USA.
Cleveland Clinic Journal of Medicine (Impact Factor: 3.37). 07/2010; 77 Suppl 3:S68-71. DOI: 10.3949/ccjm.77.s3.12
Source: PubMed

ABSTRACT The metabolic syndrome is likely to develop in patients in whom genetic predisposition, chronic stress, negative emotion, and unhealthy lifestyle habits converge. In light of the psychophysiologic aspect of most of these factors, biofeedback, relaxation, and other psychophysiologic interventions have been studied and used in patients with elements of the metabolic syndrome, particularly diabetes and hypertension. This article reviews the rationale and evidence for biofeedback for the treatment of diabetes and hypertension, which has been shown to effectively lower blood glucose and blood pressure in numerous studies. Patients with prehypertension may be a particularly appropriate target population for biofeedback for blood pressure reduction. Further research is needed to guide identification of the best candidates for psychophysiologic intervention for these conditions, although patient readiness for change is a clear prerequisite.

  • [Show abstract] [Hide abstract]
    ABSTRACT: This intervention assessed the effects of a brief intervention on dropout rate in a cardiac rehabilitation program. One hundred thirty five patients were recruited from a cardiac rehabilitation program and randomized to either a control or intervention group. The intervention group participated in four sessions of motivational interviewing and stress management-relaxation in addition to standard cardiac rehabilitation. The control group underwent cardiac rehabilitation alone. Patients who completed the intervention completed an average of 30 sessions while those who dropped out of the intervention completed about six (p < 0.001). Anxiety and depression measured at baseline were the primary predictors of dropout. Patients in both the intervention and controls groups who completed cardiac rehabilitation improved the distance walked, quality of life and decreased anxiety.
    Applied Psychophysiology and Biofeedback 08/2014; 39(3-4). DOI:10.1007/s10484-014-9252-y · 1.13 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Biofeedback training has been utilized for the treatment of different pathological conditions, in particular those related to stress/anxiety. This study reviews the scientific literature from 2008 to 2012 about the subject "biofeedback, stress and anxiety", published in MEDLINE, LILACS and Web of Sciences, using as keywords "biofeedback", "anxiety", "stress", "psychology" and "biofeedback training". The results obtained showed that biofeedback training has been successfully employed as a therapeutic tool for the management of stress/anxiety in the different populations studied. Nevertheless, all of the studies found were performed outside Brazil, which suggests that biofeedback as a therapeutic tool has not been utilized in the country for some reason that deserves to be better investigated.
    04/2013; 18(1):131-140.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Metabolic syndrome (MS) seems to be associated with both depression and increased cardiovascular risk. This article emphasizes the most relevant findings on the link between MS and psychological cardiovascular risk factors, focusing on the impact of anxiety. There is evidence for an association between psychological disorders and the development of MS, which could eventually increase cardiovascular risk. However, the coexistence of anxiety in MS patients seems to be a byproduct of anxiety–depression comorbidity, stress and negative health behaviors. Endocannabinoid receptors, and hypothalamic–pituitary–adrenal axis dysregulation and sympathetic hyperactivation are the most commonly mentioned plausible underlying pathways.
    Expert Review of Endocrinology &amp Metabolism 01/2014; 7(1). DOI:10.1586/eem.11.89